Suppr超能文献

0.05%丙酸氯倍他索洗发水对头皮银屑病的长期控制有效且安全。

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.

作者信息

Poulin Yves, Papp Kim, Bissonnette Robert, Guenther Lyn, Tan Jerry, Lynde Charles, Kerrouche Nabil, Villemagne Hervé

机构信息

Centre de Recherche Dermatologique du Québec Metropolitain, Québec City, Québec, Canada.

出版信息

Cutis. 2010 Jan;85(1):43-50.

Abstract

Clobetasol propionate (CP) shampoo 0.05% is an efficacious and safe treatment for scalp psoriasis. The aim of this double-blind, randomized, placebo-controlled study was to determine if CP shampoo is suitable for long-term disease control. Participants with moderate to severe scalp psoriasis (global severity score [GSS] of 3 or 4 on a scale of 0 [clear] to 5 [very severe]) first received once daily CP shampoo treatment for up to 4 weeks. Responders were subsequently randomized to receive the CP shampoo or vehicle twice weekly maintenance regimen for up to 6 months. When relapse occurred (defined as GSS > 2), participants resumed once daily CP shampoo treatment; when symptoms diminished (GSS < or = 2), they readopted the twice weekly maintenance regimen. At all visits significantly more participants treated with CP shampoo did not relapse compared with participants treated with vehicle (P < .001). Only approximately one-third of participants treated with vehicle remained relapse free at 1 month, while this rate was observed approximately 3.5 months later (4.5 months after baseline of maintenance phase) in the CP shampoo group. After 6 months 31.1% (33/106) of participants in the CP shampoo group were still relapse free versus 8.1% (9/111) of participants in the vehicle group. There was no greater incidence of skin atrophy, telangiectasia, or hypothalamic-pituitary-adrenal (HPA) axis suppression in the CP shampoo group compared with the vehicle group. Clobetasol propionate shampoo is efficacious and safe for acute management and long-term maintenance of moderate to severe scalp psoriasis.

摘要

0.05%丙酸氯倍他索(CP)洗发水是治疗头皮银屑病的一种有效且安全的疗法。这项双盲、随机、安慰剂对照研究的目的是确定CP洗发水是否适合长期疾病控制。中重度头皮银屑病患者(全球严重程度评分[GSS]在0[清除]至5[非常严重]的范围内为3或4)首先接受每日一次的CP洗发水治疗,为期4周。有反应者随后被随机分配接受CP洗发水或赋形剂每周两次的维持方案,为期6个月。当复发发生时(定义为GSS>2),参与者恢复每日一次的CP洗发水治疗;当症状减轻时(GSS≤2),他们重新采用每周两次的维持方案。在所有访视中,与接受赋形剂治疗的参与者相比,接受CP洗发水治疗的参与者复发的人数明显更少(P<.001)。接受赋形剂治疗的参与者中只有约三分之一在1个月时仍未复发,而在CP洗发水组中,这一比例在大约3.5个月后(维持阶段基线后4.5个月)才观察到。6个月后,CP洗发水组31.1%(33/106)的参与者仍未复发,而赋形剂组为8.1%(9/111)。与赋形剂组相比,CP洗发水组皮肤萎缩、毛细血管扩张或下丘脑-垂体-肾上腺(HPA)轴抑制的发生率没有更高。丙酸氯倍他索洗发水对于中重度头皮银屑病的急性治疗和长期维持是有效且安全的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验